tradingkey.logo
tradingkey.logo
Search

Ginkgo Bioworks Holdings Inc

DNA
Add to Watchlist
8.090USD
-0.010-0.12%
Close 07-31 16:00ETQuotes delayed by 15 min
504.21MMarket Cap
LossP/E TTM

DNA Balance Sheet

You can check out the annual or quarterly balance sheets of Ginkgo Bioworks Holdings Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Total equity
Cash, cash equivalents and short-term investments
-27.75%373.46M
-24.74%422.62M
-25.05%461.86M
-35.14%473.69M
-38.49%516.92M
-40.52%561.57M
-41.27%616.21M
-33.95%730.37M
-30.32%840.44M
-28.25%944.07M
-19.45%1.05B
-19.70%1.11B
-19.22%1.21B
-15.11%1.32B
-25.10%1.30B
483.80%1.38B
--1.49B
--1.55B
--1.74B
--235.89M
- Cash and cash equivalents
-53.95%143.86M
-70.23%167.20M
-81.98%111.06M
-72.13%203.57M
-62.83%312.42M
-40.52%561.57M
-41.27%616.21M
-33.95%730.37M
-30.32%840.44M
-28.25%944.07M
-19.45%1.05B
-19.70%1.11B
-19.22%1.21B
-15.11%1.32B
-25.10%1.30B
483.80%1.38B
--1.49B
--1.55B
--1.74B
--235.89M
-Short-term investments
12.27%229.59M
--255.42M
--350.80M
--270.13M
--204.50M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Receivables
-25.40%20.27M
8.07%24.25M
-8.61%22.36M
-22.47%23.13M
-27.26%27.17M
-29.29%22.44M
-61.25%24.46M
-56.72%29.83M
-55.97%37.35M
-62.23%31.74M
-45.45%63.14M
-62.00%68.92M
-50.41%84.84M
-43.94%84.03M
128.20%115.76M
538.99%181.38M
--171.07M
--149.90M
--50.73M
--28.39M
-Accounts and notes receivable
-25.40%20.27M
8.07%24.25M
-6.61%22.36M
22.42%23.13M
10.63%27.17M
25.39%22.44M
-62.08%23.94M
-72.59%18.89M
-71.05%24.56M
-78.30%17.90M
-45.45%63.14M
-60.59%68.92M
-50.41%84.84M
-39.43%82.47M
128.20%115.76M
516.09%174.88M
--171.07M
--136.14M
--50.73M
--28.39M
-Loans receivable
----
----
----
----
----
----
--523.00K
--10.94M
--12.79M
--12.29M
----
----
----
-100.00%0.00
----
--6.50M
----
--11.56M
----
----
-Other receivables
----
----
----
----
----
----
----
----
----
-0.96%1.55M
----
----
----
-28.98%1.56M
----
----
----
--2.20M
----
----
Inventory
----
----
----
----
----
----
----
----
----
-98.95%46.00K
-98.81%70.00K
-95.17%391.00K
-71.15%2.51M
29.80%4.36M
68.68%5.86M
198.31%8.10M
--8.70M
--3.36M
--3.47M
--2.72M
Prepaid expenses
-25.22%9.35M
39.12%17.93M
-31.08%13.06M
-26.69%15.26M
-42.92%12.50M
-36.88%12.89M
-27.25%18.95M
-19.56%20.81M
-14.86%21.90M
-55.03%20.42M
-31.08%26.04M
-19.69%25.87M
-22.28%25.72M
137.97%45.41M
118.23%37.78M
88.71%32.22M
--33.09M
--19.08M
--17.31M
--17.07M
Other current assets
-13.35%6.88M
20.41%7.03M
208.37%8.80M
365.32%10.95M
138.67%7.94M
6.77%5.84M
-14.70%2.85M
-89.53%2.35M
-59.16%3.33M
1023.00%5.47M
--3.35M
--22.48M
--8.15M
-30.23%487.00K
----
----
----
--698.00K
----
----
Total current assets
-27.38%409.95M
-21.72%471.84M
-23.61%506.08M
-33.23%523.02M
-37.48%564.53M
-39.83%602.74M
-41.98%662.48M
-35.97%783.36M
-31.97%903.02M
-30.92%1.00B
-21.90%1.14B
-23.48%1.22B
-22.19%1.33B
-15.84%1.45B
-19.25%1.46B
462.84%1.60B
--1.71B
--1.72B
--1.81B
--284.07M
Non-current assets
Net Fixed Assets
-11.08%516.82M
-11.61%528.70M
-11.70%544.79M
-10.57%562.15M
39.46%581.22M
51.43%598.15M
13.57%616.95M
-8.33%628.59M
-40.65%416.78M
-44.80%394.99M
189.59%543.21M
289.10%685.67M
370.76%702.24M
390.87%715.53M
31.44%187.58M
20.80%176.22M
--149.17M
--145.77M
--142.70M
--145.88M
-Fixed Assets
-5.16%706.20M
-5.23%719.30M
-5.32%726.87M
-3.81%735.64M
36.17%744.64M
47.18%759.03M
15.63%767.68M
-4.89%764.82M
-32.44%546.86M
-36.20%515.71M
144.98%663.92M
216.05%804.14M
269.72%809.50M
290.81%808.29M
37.89%271.01M
32.70%254.43M
--218.95M
--206.82M
--196.54M
--191.74M
-Accumulated depreciation
15.88%189.38M
18.48%190.60M
20.79%182.07M
27.36%173.50M
25.62%163.42M
33.26%160.87M
24.87%150.74M
14.99%136.23M
21.28%130.09M
30.15%120.72M
44.68%120.71M
51.47%118.47M
53.71%107.26M
51.93%92.76M
54.98%83.43M
70.56%78.21M
--69.78M
--61.05M
--53.84M
--45.85M
Goodwill and other intangible assets
-28.94%48.86M
-21.49%56.92M
-22.68%61.52M
-26.99%66.15M
-45.13%68.76M
-45.06%72.51M
-49.71%79.57M
-44.71%90.60M
-25.17%125.32M
-22.93%131.98M
106.18%158.22M
133.58%163.86M
299.96%167.46M
298.68%171.25M
95.63%76.74M
1338.45%70.15M
--41.87M
--42.95M
--39.23M
--4.88M
Long-term debt
----
----
----
----
----
--14.17M
--14.61M
--14.78M
--14.47M
----
----
----
----
----
----
----
----
--0.00
--10.16M
--16.65M
Other non-current assets
-15.51%39.52M
14.58%47.17M
3.13%46.59M
3.49%47.02M
1.36%46.78M
-29.09%41.17M
-53.43%45.18M
-53.61%45.44M
-52.55%46.15M
-34.57%58.05M
120.87%97.02M
84.75%97.95M
96.03%97.26M
101.69%88.72M
63.90%43.93M
108.40%53.02M
--49.62M
--43.99M
--26.80M
--25.44M
Total non-current assets
-14.52%623.12M
-16.37%647.86M
-16.53%683.08M
-15.91%707.98M
7.39%728.93M
16.74%774.71M
-7.48%818.40M
-21.21%841.89M
-37.72%678.74M
-39.08%663.59M
116.43%884.55M
170.26%1.07B
209.72%1.09B
213.05%1.09B
20.20%408.69M
30.49%395.37M
--351.89M
--347.94M
--340.02M
--302.98M
Total assets
-20.13%1.03B
-18.71%1.12B
-19.70%1.19B
-24.26%1.23B
-18.23%1.29B
-17.29%1.38B
-26.92%1.48B
-29.09%1.63B
-34.56%1.58B
-34.42%1.67B
8.32%2.03B
14.93%2.29B
17.47%2.42B
22.61%2.54B
-13.01%1.87B
239.70%1.99B
--2.06B
--2.07B
--2.15B
--587.04M
Liabilities
Current liabilities
-Other payables
----
----
--0.00
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Accrued expenses
-31.62%48.38M
1.64%66.46M
4.63%79.34M
-51.13%57.23M
-34.76%70.75M
-40.58%65.39M
-34.03%75.83M
6.01%117.12M
-11.56%108.44M
-4.05%110.05M
57.48%114.95M
57.69%110.48M
38.15%122.61M
22.89%114.69M
36.29%72.99M
48.99%70.06M
--88.76M
--93.33M
--53.55M
--47.02M
Deferred liabilities
-55.69%14.91M
-31.63%18.95M
10.23%25.24M
8.77%28.29M
0.12%33.65M
-37.71%27.71M
-46.46%22.89M
-33.69%26.01M
-29.26%33.61M
-6.97%44.49M
5.57%42.76M
-13.80%39.22M
34.87%47.52M
43.85%47.82M
36.62%40.51M
45.38%45.50M
--35.23M
--33.24M
--29.65M
--31.30M
Other current liabilities
-55.69%14.91M
-31.63%18.95M
10.23%25.24M
8.77%28.29M
0.12%33.65M
-37.71%27.71M
-46.46%22.89M
-33.69%26.01M
-29.26%33.61M
-6.97%44.49M
5.57%42.76M
-13.80%39.22M
34.87%47.52M
43.85%47.82M
36.62%40.51M
45.38%45.50M
--35.23M
--33.24M
--29.65M
--31.30M
Total current liabilities
-31.19%79.59M
-10.53%95.97M
0.75%115.28M
-41.79%96.72M
-31.58%115.67M
-34.54%107.27M
-32.08%114.43M
1.73%166.15M
-11.82%169.04M
-5.26%163.86M
34.97%168.46M
20.97%163.33M
20.38%191.70M
28.35%172.96M
38.22%124.82M
66.51%135.02M
--159.25M
--134.76M
--90.31M
--81.09M
Non-current liabilities
Long-term debt and lease liabilities
-5.49%410.70M
-4.94%417.08M
-5.10%422.87M
-5.18%428.83M
85.32%434.56M
97.79%438.77M
10.39%445.59M
10.06%452.26M
-41.97%234.50M
-46.32%221.84M
--403.66M
--410.94M
--404.10M
--413.26M
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-Long-term lease liabilities
-5.49%410.70M
-4.94%417.08M
-5.10%422.87M
-5.18%428.83M
85.32%434.56M
97.79%438.77M
10.39%445.59M
10.06%452.26M
-41.97%234.50M
-46.32%221.84M
--403.66M
--410.94M
--404.10M
--413.26M
----
----
----
----
----
----
Deferred liabilities
-3.09%77.89M
-23.89%75.18M
-29.62%74.07M
-51.22%74.57M
-51.60%80.38M
-37.50%98.78M
-38.09%105.25M
-15.03%152.87M
-5.00%166.07M
-9.56%158.06M
12.86%170.01M
14.60%179.90M
2.73%174.81M
12.04%174.77M
-7.61%150.64M
36.03%156.98M
--170.18M
--155.99M
--163.04M
--115.40M
Derivatives liabilities
----
----
----
----
----
----
----
----
----
-47.55%5.70M
-69.16%12.26M
-48.17%14.15M
-80.98%9.66M
-92.00%10.87M
-81.34%39.74M
--27.29M
--50.80M
--135.84M
--212.94M
----
Other non-current liabilities
3.99%99.63M
-15.00%98.06M
-25.78%91.23M
-46.76%92.51M
-49.83%95.81M
-34.75%115.36M
-35.08%122.92M
-13.12%173.76M
-6.47%190.95M
-14.16%176.79M
-8.34%189.33M
-6.24%200.00M
-1.05%204.16M
-2.26%205.96M
-3.07%206.56M
59.41%213.30M
--206.32M
--210.73M
--213.11M
--133.81M
Total non-current liabilities
-3.78%510.33M
-7.04%515.14M
-9.57%514.10M
-16.72%521.34M
24.66%530.37M
37.05%554.13M
-6.07%568.51M
0.15%626.03M
-31.15%425.45M
-35.83%404.33M
97.70%605.25M
113.97%625.08M
117.25%617.92M
70.82%630.08M
-30.79%306.14M
94.54%292.14M
--284.43M
--368.85M
--442.31M
--150.17M
Total liabilities
-8.69%589.92M
-7.60%611.11M
-7.84%629.38M
-21.98%618.06M
8.67%646.04M
16.40%661.39M
-11.73%682.94M
0.48%792.18M
-26.57%594.49M
-29.25%568.19M
79.53%773.71M
84.57%788.41M
82.48%809.62M
59.46%803.04M
-19.09%430.96M
84.71%427.16M
--443.68M
--503.61M
--532.62M
--231.26M
Shareholders' equity
Common equity
1.49%6.67B
1.55%6.66B
1.53%6.63B
1.41%6.60B
2.04%6.58B
2.65%6.56B
3.05%6.53B
3.62%6.51B
3.76%6.45B
4.07%6.39B
11.74%6.33B
23.20%6.28B
38.92%6.21B
61.28%6.14B
151.99%5.67B
440.04%5.10B
--4.47B
--3.81B
--2.25B
--944.05M
Preferred equity
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--184.00K
Retained earnings
-5.13%-6.23B
-5.36%-6.15B
-5.93%-6.07B
-5.56%-5.99B
-8.65%-5.93B
-10.34%-5.84B
-12.82%-5.73B
-18.80%-5.67B
-18.55%-5.46B
-20.30%-5.29B
-20.17%-5.08B
-34.26%-4.78B
-59.35%-4.60B
-91.38%-4.40B
-506.12%-4.23B
-497.47%-3.56B
---2.89B
---2.30B
---697.27M
---595.39M
Capital reserves
1.49%6.67B
1.55%6.66B
1.53%6.63B
1.41%6.60B
2.04%6.58B
2.65%6.56B
3.05%6.53B
3.62%6.51B
3.76%6.45B
4.07%6.39B
11.74%6.33B
23.20%6.28B
38.92%6.21B
61.28%6.14B
152.00%5.67B
440.06%5.10B
--4.47B
--3.80B
--2.25B
--943.97M
Gains losses not affecting retained earnings
240.47%1.19M
202.49%1.85M
658.94%2.00M
195.94%1.65M
45.20%-850.00K
-221.70%-1.81M
109.07%263.00K
-32.54%-1.72M
3.90%-1.55M
156.38%1.48M
63.35%-2.90M
76.35%-1.30M
31.46%-1.61M
-53.47%-2.63M
-801.94%-7.91M
---5.50M
---2.35M
---1.71M
---877.00K
----
Non-controlling interests
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
-100.00%0.00
-92.47%5.00M
355.43%31.63M
--33.25M
--62.01M
--66.42M
--6.94M
Total equity
-31.55%443.15M
-28.97%508.59M
-29.85%559.78M
-26.42%612.95M
-34.42%647.43M
-34.73%716.06M
-36.30%797.94M
-44.59%833.07M
-38.59%987.27M
-36.81%1.10B
-12.99%1.25B
-4.05%1.50B
-0.40%1.61B
10.78%1.74B
-11.02%1.44B
340.45%1.57B
--1.61B
--1.57B
--1.62B
--355.79M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

Which balance sheet metrics matter most when analyzing DNA stock?

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does Ginkgo Bioworks Holdings Inc Have?

In its most recent quarterly, Ginkgo Bioworks Holdings Inc had 143.86M in cash and cash equivalents.

How Much Are Ginkgo Bioworks Holdings Inc's Total Liabilities?

Ginkgo Bioworks Holdings Inc reported 611.11M in total liabilities as of the latest reported quarter, including 95.97M in current liabilities and 515.14M in non-current liabilities.

What Are Ginkgo Bioworks Holdings Inc's Total Assets?

As of the latest reported quarter, Ginkgo Bioworks Holdings Inc's total assets were 1.12B, consisting of 471.84M in current assets and 647.86M in non-current assets.

How Much Shareholders' Equity Does Ginkgo Bioworks Holdings Inc Have?

Ginkgo Bioworks Holdings Inc reported 508.59M in total shareholders' equity as of the latest reported quarter.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.